Ligand Pharmaceuticals reported $47.63M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Amgen USD 9.18B 1.03B Jun/2025
Arrowhead Research USD 27.77M 514.94M Jun/2025
Baxter International USD 2.81B 180M Jun/2025
Bristol-Myers Squibb USD 12.27B 1.07B Jun/2025
Eli Lilly USD 15.56B 2.83B Jun/2025
Gilead Sciences USD 7.1B 430M Jun/2025
GlaxoSmithKline GBP 7.99B 470M Jun/2025
Glaxosmithkline GBP 7.99B 131M Jun/2025
Insmed USD 107.4M 14.58M Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
Ligand Pharmaceuticals USD 47.63M 2.3M Jun/2025
MacroGenics USD 22.24M 2.89M Jun/2025
Merck USD 15.81B 280M Jun/2025
Pacira USD 181.1M 12.18M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
Veracyte USD 130.16M 15.69M Jun/2025